FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Modip

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

33 API Suppliers, 16 USDMF, 10 CEP/COS, 1 JDMF, 4 EU WC, 14 KDMF, 4 NDC API, 9 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

FINISHED DOSAGE FORMULATIONS

261 FDF Dossiers, 44 FDA Orange Book, 156 Europe, 8 Canada, 18 Australia, 7 South Africa, 28 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Minakem, 5 SPI Pharma, 1 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Kirsch Pharma, 1 Panvo Organics, 1 ACG Worldwide, 5 Actylis, 3 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 21 BASF, 1 CD Formulation, 1 Clariant, 11 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 11 Gangwal Chemicals, 2 Gloria Interchem, 4 Ideal Cures, 2 Ingredion Pharma Solutions, 24 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 7 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 3 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 14 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 1 Silverline Chemicals, 2 The Dow Chemical Company, 2 Valens Pharmachem, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Fillers, Diluents & Binders, 39 Coating Systems & Additives, 28 Solubilizers, 28 Direct Compression, 24 Granulation, 23 Controlled & Modified Release, 21 Thickeners and Stabilizers, 19 Topical, 15 Film Formers & Plasticizers, 13 Lubricants & Glidants, 12 Co-Processed Excipients, 12 Parenteral, 10 Disintegrants & Superdisintegrants, 9 Emulsifying Agents, 9 Chewable & Orodispersible Aids, 7 API Stability Enhancers, 7 Taste Masking, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 4 Rheology Modifiers, 2 Coloring Agents

DIGITAL CONTENT

6 News #PharmaBuzz

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions, 34 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

10 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 Health Canada Patents

8 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Labeler	NDC Package Code	Non Proprietary Name	Start Marketing Date	End Marketing Date	Category Code	Dosage Form (Strength)
27/02/2026	Aurobindo Pharma Limited	India	Aurobindo Pharma Limited	65862-399	Felodipine	2024-01-08	2026-12-31	BULK INGREDIENT	POWDER (50kg/50kg)
27/02/2026	Everlight Chemical	Taiwan	Everlight Chemical Industrial Corporation Kuanyin II Plant	65035-105	Felodipine	2016-08-17	2026-12-31	BULK INGREDIENT	POWDER (1000g/1000g)

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Modip

Modip

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

33 API Suppliers

16 USDMF

10 CEP/COS

1 JDMF

4 EU WC

14 KDMF

4 NDC API

9 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

7 Drugs in Development

FINISHED DOSAGE FORMULATIONS

261 FDF Dossiers

44 FDA Orange Book

156 Europe

8 Canada

18 Australia

7 South Africa

28 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Minakem

5 SPI Pharma

1 Boai NKY Pharmaceuticals Ltd

4 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Kirsch Pharma

1 Panvo Organics

1 ACG Worldwide

5 Actylis

3 Aeon Procare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

21 BASF

1 CD Formulation

1 Clariant

11 Corel Pharma Chem

5 DFE Pharma

1 Esteem Industries

2 Finar

11 Gangwal Chemicals

2 Gloria Interchem

4 Ideal Cures

2 Ingredion Pharma Solutions

24 Kerry

1 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

7 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

3 Pharmatrans-Sanaq

3 Pluviaendo

1 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

15 Roquette

14 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

1 Silverline Chemicals

2 The Dow Chemical Company

2 Valens Pharmachem

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Fillers, Diluents & Binders

39 Coating Systems & Additives

28 Solubilizers

TABLET, EXTENDED RELEASE;ORAL - 10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 2.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons